Global Women’s Health Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Women’s Health Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Women’s health diagnostics market is growing due to the increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer.
Global Women’s Health Diagnostics market is projected to reach US$ 43800 million in 2029, increasing from US$ 27230 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Breast Cancer and Infectious Disease Testing are the major drivers for the industry.
North America dominates the women's health diagnostics market owing to rising adoption of technologically advanced products. Moreover, government initiatives and product launches will further drive the growth of the women’s health diagnostics market in the region over the forecast period. The women's health diagnostics market in Asia Pacific is expected to witness substantial growth owing to improving healthcare infrastructure. In addition, initiatives taken by the government have increased women's participation in the workforce. Moreover, rising awareness about women's health disorders is expected to further drive the growth of the women's health diagnostics market in the region in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Women’s Health Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Abbott Laboratories
Roche
Philips
Siemens
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Biomerieux SA
Quest Diagnostics Inc.
Hologic, Inc.
Segment by Type
Diagnostic Devices
Diagnostic Tests
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Women’s Health Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Women’s Health Diagnostics introduction, etc. Women’s Health Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Women’s Health Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Women’s Health Diagnostics market is projected to reach US$ 43800 million in 2029, increasing from US$ 27230 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Breast Cancer and Infectious Disease Testing are the major drivers for the industry.
North America dominates the women's health diagnostics market owing to rising adoption of technologically advanced products. Moreover, government initiatives and product launches will further drive the growth of the women’s health diagnostics market in the region over the forecast period. The women's health diagnostics market in Asia Pacific is expected to witness substantial growth owing to improving healthcare infrastructure. In addition, initiatives taken by the government have increased women's participation in the workforce. Moreover, rising awareness about women's health disorders is expected to further drive the growth of the women's health diagnostics market in the region in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Women’s Health Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Abbott Laboratories
Roche
Philips
Siemens
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Biomerieux SA
Quest Diagnostics Inc.
Hologic, Inc.
Segment by Type
Diagnostic Devices
Diagnostic Tests
Segment by Application
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Women’s Health Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Women’s Health Diagnostics introduction, etc. Women’s Health Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Women’s Health Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.